QR Code

Prostate neuroendocrine carcinoma successfully treated with etoposide and cisplatin

Introduction The frequency of neuroendocrine carcinoma of the prostate is low, accounting for approximately 1%–5% of all prostate cancers. Herein, we report the case of a patient who was diagnosed with prostate neuroendocrine carcinoma and successfully treated with etoposide and cisplatin. Case pres...

Full description

Saved in:
Main Authors: Masanori Ishizaki, Masaru Hasumi, Kazumichi Muramatsu, Nobuaki Shimizu
Format: Artigo
Language:Inglês
Published: Wiley 2024-11-01
Series:IJU Case Reports
Subjects:
cisplatin
etoposide
metastasis
neuroendocrine carcinoma
prostate
Online Access:https://doi.org/10.1002/iju5.12787
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items